-
Characteristics of RWE used in Regulatory Decision-Making for Marketing Authorization Applications (MAAs)
Mar 27, 2025, 21:40 PM -
Implementation of the IRA: Evolving Perspectives from US Stakeholders
Mar 27, 2025, 21:40 PM -
Feasibility of Replicating a Published Health Economic Model From an ICER Report Using Generative AI
Mar 27, 2025, 21:40 PM -
A Bayesian State-Transition Model-Based Approach to Estimate Transition Rates From Aggregated Survival Data
Mar 27, 2025, 21:40 PM -
Application of Bayesian Meta-Analysis in Synthesizing Health State Utility Values for QALY Estimation in Health Economic Evaluations: A Case Study on Advanced Neuroendocrine Tumors
Mar 27, 2025, 21:40 PM -
Balancing Innovation and Affordability: Analyzing the Cost of Drugs for Rare Diseases in Canada
Mar 27, 2025, 21:40 PM -
Impact of JCA and Project Orbis on the European Revenue Potential of an Oncology Product
Mar 27, 2025, 21:40 PM -
Quantifying Treatment Value Using Alternative Health Benefit Metrics: A Case Study of Adjuvant Osimertinib for Elderly Patients with EGFR mutated NSCLC Following Resection
Mar 27, 2025, 21:40 PM -
A Health Technology Assessment Framework for Ethics Analysis in Drug Reimbursement Reviews at Canada's Drug Agency
Mar 27, 2025, 21:40 PM -
Alignment Between CDA Recommendations and pCPA Negotiation Outcomes: Exploring Factors Influencing Reimbursement Success
Mar 27, 2025, 21:40 PM -
Impact of Medicaid Enrollment Provisions on Postpartum Coverage and Resource Use in Three US States
Mar 27, 2025, 21:40 PM -
How Can We Make Innovative Payment and Pricing Schemes Work? Findings of the European Union Research Project HI-PRIX
Mar 27, 2025, 21:40 PM -
Access to Care and Ability to Afford Prescription and Medical Treatment Among Adults With Obesity in the United States
Mar 27, 2025, 21:40 PM -
A Policy Framework for Multi-Indication Evidence Synthesis in Oncology Health Technology Assessment (HTA)
Mar 27, 2025, 21:40 PM -
Biosimilar Optimization in Community Oncology Practices
Mar 27, 2025, 21:40 PM -
Is There Any difference in Preferences Between Patients and Physicians? Evidence From Anti-Hyperglycemic Medications Choices for Type 2 Diabetes
Mar 27, 2025, 21:39 PM -
Patient Preferences on Understanding Medical Tests and Monitoring Equipment in Hospitalized Care
Mar 27, 2025, 21:39 PM -
Incorporating External Opinion in Survival Extrapolations to Inform Long-Term Survival Projections for Health Technology Assessment
Mar 27, 2025, 21:39 PM -
Probabilistic Attribute Presentation in Discrete Choice Experiments (DCEs): A Review of Current Practice
Mar 27, 2025, 21:39 PM -
Predicting Overall Survival (OS) from Time to Recurrence (TTR) Using a Copula-Based Patient-Level Surrogacy Model with Parametric Marginal Survival Distributions: Application to Adjuvant Treatment of Patients with Colon Cancer
Mar 27, 2025, 21:39 PM